Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QIVIGY in Stiff Person Syndrome
NCT07552987Phase 3Not yet recruiting
- Sponsor
- Kedrion Biopharma
- Start
- Nov 2026
- Primary completion
- Jan 2028
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of immune globulin intravenous (human) in stiff person syndrome (SPS), sponsored by Kedrion Biopharma. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
immune globulin intravenous (human)
03
Conditions
stiff person syndrome (SPS)
Beyond the preview
Go deeper on NCT07552987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552987.